Cogent Biosciences Profit Margin 2016-2021 | COGT
Current and historical gross margin, operating margin and net profit margin for Cogent Biosciences (COGT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Cogent Biosciences net profit margin as of June 30, 2021 is 0%.
|Cogent Biosciences Annual Profit Margins
|Cogent Biosciences Quarterly Profit Margins
||Medical - Biomedical and Genetics
Cogent Biosciences Inc. is a biotechnology company. It is focused on developing precision therapies for genetically defined diseases. The company's program consist PLX9486. Cogent Biosciences Inc., formerly known as Unum Therapeutics Inc., is based in CAMBRIDGE, Mass.